HCC CONNECT is an international group of experts in the field of hepatocellular carcinoma and is an initiative of COR2ED. The group discusses the latest scientific and clinical insights, identifies educational needs, and develops educational programmes to support healthcare professionals globally to provide the best possible care to their patients.
HCC CONNECT is an initiative of COR2ED, supported by Independent Medical Educational Grants from AstraZeneca, Bayer and Eisai Europe Limited.
What’s new from HCC CONNECT
Interactive patient case
Episode
2
of 2
Advanced HCC: Treatment options for patients ineligible for IO
Explore treatment options, adverse event management and next steps in this interactive patient case
Experts
Prof. Sammy SaabEndorsed by
-
15 MIN
-
Jan 2024
Interactive patient case
Episode
1
of 2
Advanced HCC: When to switch to 2nd line treatment
Explore treatment selection and optimal sequencing after progression on immunotherapy in an interactive patient case video
Experts
Dr Timon VandammeEndorsed by
-
15 MIN
-
Dec 2023
Publication
Surveillance and Diagnosis of HCC in Asia: Poster Presentation at ILCA 2023
Data from an Asia-Pacific patient and HCP survey
Experts
Prof. Chee-Kiat Tan-
Downloadable
Resources -
5 MIN
-
Sep 2023
Podcast
Episode
2
of 2
A New Era in Treating Patients with Advanced HCC
2nd line treatment selection and the right time to switch
Experts
Prof. Dr Jeroen Dekervel, Dr Amit SingalEndorsed by
-
Downloadable
Resources -
29 MIN
-
Aug 2023
Micro learning
Module
2
of 2
The Use of Immunotherapy in HCC
Module 2: In-depth Subgroup Analyses and Challenges
Experts
Prof. Dr Peter R. Galle, Dr Aiwu Ruth HeEndorsed by
-
Downloadable
Resources -
4 MIN
-
Jun 2023
Video
Episode
4
of 4
Treatment Options for HCC Patients Not Eligible for or Progressed on Immunotherapy
Episode 4: Panel Discussion and Summary
Experts
Prof. Michel Ducreux, Dr Timon Vandamme, Asst. Prof. Changhoon YooEndorsed by
-
Downloadable
Resources -
15 MIN
-
Jun 2023
